×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Contact Us
About Us
Subscribe
My Portfolio
My Account
Contact Us
About Us
Subscribe
My Account
My Portfolio
Logo

Insider Transactions by Nadim Ahmed

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
CGEMCullinan Therapeutics, Inc.Nadim AhmedPresident and CEOFeb 25, 2025Sale$8.5312,529106,872430,621Feb 27, 2025, 05:00 PM
CGEMCullinan Therapeutics, Inc.Nadim AhmedPresident and CEODec 24, 2024Sale$11.878,40099,708263,150Dec 27, 2024, 06:00 PM
CGEMCullinan Oncology, Inc.Nadim AhmedPresident and CEODec 26, 2023Sale$9.244,27239,473111,550Dec 27, 2023, 06:30 PM
CGEMCullinan Oncology, Inc.Nadim AhmedPresident and CEOJun 28, 2023Sale$11.407598,653115,822Jun 29, 2023, 04:59 PM
CGEMCullinan Oncology, Inc.Nadim AhmedPresident and CEOMay 23, 2023Sale$9.157076,469116,581May 24, 2023, 04:36 PM
CGEMCullinan Oncology, Inc.Nadim AhmedPresident and CEOApr 25, 2023Sale$10.597167,582117,288Apr 26, 2023, 04:23 PM
CGEMCullinan Oncology, Inc.Nadim AhmedPresident and CEOMar 23, 2023Sale$10.517067,420118,004Mar 27, 2023, 04:05 PM
CGEMCullinan Oncology, Inc.Nadim AhmedPresident and CEOJun 30, 2022Award/Grant$10.901,62017,6589,710Jul 05, 2022, 06:04 PM
CGEMCullinan Oncology, Inc.Nadim AhmedPresident and CEOJun 06, 2022Buy$12.408,090100,3168,090Jun 07, 2022, 04:33 PM
BMYBRISTOL MYERS SQUIBB CONadim AhmedEVP and President, HematologyDec 31, 2020Option/RSU Exercise-14,946-46,549Jan 05, 2021, 08:13 PM
BMYBRISTOL MYERS SQUIBB CONadim AhmedEVP and President, HematologyDec 31, 2020Tax Payment (Shares)$62.037,660475,15038,889Jan 05, 2021, 08:13 PM
BMYBRISTOL MYERS SQUIBB CONadim AhmedEVP and President, HematologyDec 02, 2020Tax Payment (Shares)$62.183,380210,16831,603Dec 03, 2020, 08:24 PM
BMYBRISTOL MYERS SQUIBB CONadim AhmedEVP and President, HematologyDec 02, 2020Option/RSU Exercise-6,594-34,983Dec 03, 2020, 08:24 PM
BMYBRISTOL MYERS SQUIBB CONadim AhmedEVP and President, HematologyOct 30, 2020Tax Payment (Shares)$58.452,291133,90928,389Nov 03, 2020, 04:28 PM
BMYBRISTOL MYERS SQUIBB CONadim AhmedEVP and President, HematologyOct 30, 2020Option/RSU Exercise-4,650-30,680Nov 03, 2020, 04:28 PM
BMYBRISTOL MYERS SQUIBB CONadim AhmedEVP and President, HematologyMay 01, 2020Option/RSU Exercise-2,908-27,463May 05, 2020, 04:49 PM
BMYBRISTOL MYERS SQUIBB CONadim AhmedEVP and President, HematologyMay 01, 2020Tax Payment (Shares)$60.261,43386,35326,030May 05, 2020, 04:49 PM
BMYBRISTOL MYERS SQUIBB CONadim AhmedPresident, HematologyMar 01, 2020Tax Payment (Shares)$59.068,473500,41524,555Mar 03, 2020, 08:04 PM
BMYBRISTOL MYERS SQUIBB CONadim AhmedPresident, HematologyMar 01, 2020Option/RSU Exercise-17,204-33,028Mar 03, 2020, 08:04 PM
BMYBRISTOL MYERS SQUIBB CONadim AhmedPresident, HematologyFeb 04, 2020Tax Payment (Shares)$64.291,07168,85515,824Feb 06, 2020, 08:48 PM
BMYBRISTOL MYERS SQUIBB CONadim AhmedPresident, HematologyFeb 04, 2020Option/RSU Exercise-2,076-16,895Feb 06, 2020, 08:48 PM

Looking for more premium content?

We have created a comprehensive group of tools that allows you to estimate the intrinsic value of investments.

Subscribe